Compounds > quinoline
Page last updated: 2024-08-17

quinoline and Cancer of Prostate

quinoline has been researched along with Cancer of Prostate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chao, MW; Chen, MC; Eight Lin, T; Hsu, KC; Lai, MJ; Lin, MH; Liou, JP; Nepali, K; Pan, SL; Peng, SJ1
Bertini, S; Bifulco, M; Carpi, S; Ciaglia, E; Di Marzo, V; Fogli, S; Gazzerro, P; Laezza, C; Ligresti, A; Lucchesi, V; Macchia, M; Malfitano, AM; Manera, C; Nieri, P; Parkkari, T; Pisanti, S; Saccomanni, G; Savinainen, JR1
Fan, Y; Guo, H; Li, K; Li, Y; Liu, D; Ma, T; Wen, J; Zhao, L; Zhou, D1

Other Studies

3 other study(ies) available for quinoline and Cancer of Prostate

ArticleYear
Amide-tethered quinoline-resorcinol conjugates as a new class of HSP90 inhibitors suppressing the growth of prostate cancer cells.
    Bioorganic chemistry, 2019, Volume: 91

    Topics: Amides; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; HSP90 Heat-Shock Proteins; Humans; Male; Models, Molecular; Molecular Structure; PC-3 Cells; Prostatic Neoplasms; Quinolines; Resorcinols; Structure-Activity Relationship; Tumor Cells, Cultured

2019
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity.
    European journal of medicinal chemistry, 2015, Jun-05, Volume: 97

    Topics: Amides; Anti-Inflammatory Agents; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Survival; Humans; Male; Molecular Structure; Multiple Sclerosis; Naphthyridines; Prostatic Neoplasms; Quinolines; Receptor, Cannabinoid, CB2; Reference Standards

2015
Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors.
    Bioorganic & medicinal chemistry, 2016, Apr-15, Volume: 24, Issue:8

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Molecular Structure; Prostatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Quinolines; Structure-Activity Relationship

2016